Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Head and Neck Neoplasms 1

Interventions

Specimen Handling 468Magnetic Resonance Spectroscopy 362pembrolizumab 289Biopsy 253Carboplatin 237Cisplatin 199Cyclophosphamide 192Paclitaxel 169Nivolumab 157Gemcitabine 146Radiotherapy 131Bevacizumab 120Dexamethasone 112fludarabine 102Fluorouracil 99Radiation 98Docetaxel 97Pemetrexed 96Doxorubicin 95durvalumab 90Oxaliplatin 89Rituximab 88venetoclax 87atezolizumab 83Leucovorin 81Capecitabine 80Prednisone 74Lenalidomide 74Etoposide 73X-Rays 70

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
nimotuzumab × 30 days × Clear all
NCT07601737 2026-05-22

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Recruiting
182 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡